Michael Petusky
Stock Analyst at Barrington
(3.42)
# 2,356
Out of 4,988 analysts
657
Total ratings
44%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Reiterated: Buy | $6.25 | $4.46 | +40.13% | 40 | Sep 3, 2026 | |
| VMD Viemed Healthcare | Initiated Coverage: Buy | $14 | $8.91 | +57.13% | 1 | Aug 24, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $95 → $118 | $108.40 | +8.86% | 67 | Aug 19, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Buy | $90 → $98 | $82.47 | +18.83% | 60 | Aug 10, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Buy | $17 → $15 | $9.54 | +57.23% | 57 | Aug 10, 2026 | |
| BVS Bioventus | Reiterated: Buy | $14 → $18 | $12.91 | +39.43% | 7 | Aug 6, 2026 | |
| LMAT LeMaitre Vascular | Downgraded: Hold | $120 → $95 | $78.87 | +20.45% | 57 | Aug 6, 2026 | |
| OFIX Orthofix Medical | Reiterated: Buy | $17 → $14 | $8.71 | +60.73% | 13 | Aug 6, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $97 → $104 | $84.84 | +22.58% | 46 | Aug 5, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $107 → $114 | $85.37 | +33.54% | 82 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $21 | $20.81 | +0.91% | 50 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $33 | $24.30 | +35.80% | 58 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.67 | - | 54 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 → $1.5 | $0.795 | +88.68% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.015 | n/a | 44 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $47.26 | n/a | 1 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $30 | $23.30 | n/a | 1 | Apr 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6.5 | $1.01 | n/a | 1 | Aug 14, 2013 |
Lifecore Biomedical
Sep 3, 2026
Reiterated: Buy
Price Target: $6.25
Current: $4.46
Upside: +40.13%
Viemed Healthcare
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $8.91
Upside: +57.13%
Haemonetics
Aug 19, 2026
Reiterated: Buy
Price Target: $95 → $118
Current: $108.40
Upside: +8.86%
U.S. Physical Therapy
Aug 10, 2026
Reiterated: Buy
Price Target: $90 → $98
Current: $82.47
Upside: +18.83%
DENTSPLY SIRONA
Aug 10, 2026
Reiterated: Buy
Price Target: $17 → $15
Current: $9.54
Upside: +57.23%
Bioventus
Aug 6, 2026
Reiterated: Buy
Price Target: $14 → $18
Current: $12.91
Upside: +39.43%
LeMaitre Vascular
Aug 6, 2026
Downgraded: Hold
Price Target: $120 → $95
Current: $78.87
Upside: +20.45%
Orthofix Medical
Aug 6, 2026
Reiterated: Buy
Price Target: $17 → $14
Current: $8.71
Upside: +60.73%
Henry Schein
Aug 5, 2026
Reiterated: Buy
Price Target: $97 → $104
Current: $84.84
Upside: +22.58%
Merit Medical Systems
Jul 31, 2026
Reiterated: Buy
Price Target: $107 → $114
Current: $85.37
Upside: +33.54%
Jul 30, 2026
Reiterated: Buy
Price Target: $17 → $21
Current: $20.81
Upside: +0.91%
Jul 30, 2026
Reiterated: Buy
Price Target: $32 → $33
Current: $24.30
Upside: +35.80%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.67
Upside: -
Jan 6, 2026
Reiterated: Buy
Price Target: $1 → $1.5
Current: $0.795
Upside: +88.68%
May 12, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.015
Upside: n/a
Jun 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $47.26
Upside: n/a
Dec 18, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 25, 2016
Upgraded: Buy
Price Target: $30
Current: $23.30
Upside: n/a
Aug 14, 2013
Rated: Buy
Price Target: $6.5
Current: $1.01
Upside: n/a